Mexico Pharmaceuticals Report - Q2 2025

Abstract

Despite challenges in drug procurement and patent enforcement, Mexico's pharmaceutical industry is on track for sustained growth. This anticipated expansion is driven by rising demand for advanced chronic disease treatments. As the second largest pharmaceutical market in Latin America, Mexico presents significant opportunities for companies developing innovative medications. However, relatively low per capita spending on pharmaceuticals may limit the widespread adoption of patented drugs, potentially increasing the market share of generics. Government initiatives to enhance local drug manufacturing are likely to encourage more international partnerships, especially in technological exchange.